Kronox Lab Sciences Soars with a Strong IPO Debut

Kronox Lab Sciences shares ended with an 18% premium on Monday against the issue price of Rs 136. The IPO saw a strong reception with the stock listing on BSE at Rs 165 and NSE at Rs 164.95, closing at Rs 159.35 and Rs 159.90 respectively. The IPO was subscribed 117.25 times.

Shares of Kronox Lab Sciences saw a remarkable debut on Monday, closing with an 18% premium from its issue price of Rs 136.

The stock commenced trading at Rs 165, reflecting a 21.32% increase on the BSE, and eventually settled at Rs 159.35, appreciating by 17.16%.

On the NSE, it opened at Rs 164.95, marking a significant 21.28% rise, and closed at Rs 159.90, up 17.57%, with the company's market valuation reaching Rs 591.25 crore.

The initial public offer was well-received, achieving 117.25 times subscription by the close of bidding on Wednesday, with shares priced in the range of Rs 129-136.

Based in Vadodara, Kronox Lab Sciences is a leading producer of high-purity speciality fine chemicals, offering over 185 products utilized in various sectors including pharmaceuticals, nutraceuticals, biotech, and personal care.

The company exports to over 20 countries, including the US, UK, Mexico, Australia, and Egypt. It operates three manufacturing facilities and an RDT laboratory in Gujarat, and has acquired land in Dahej for a new manufacturing plant.